Loading clinical trials...
Loading clinical trials...
The purpose of the study is to investigate whether eight weeks of treatment with flexible doses of bifeprunox is superior to treatment with placebo in depressed patients with bipolar disorder.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Collaborators
NCT07589647 · Bipolar Disorder (BD)
NCT06226025 · Bipolar Disorder, Delayed Sleep-Wake Phase Disorder
NCT07140913 · Mania, Bipolar Disorder
NCT06920940 · Bipolar Disorder (BD), Bipolar Disorder NOS, and more
NCT07172516 · Bipolar Disorder, Bipolar Depression, and more
Birmingham, Alabama
Beverly Hills, California
National City, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions